References:
- Liang J, Wallace G, Mootrey G. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose. Centers for Disease Control and Prevention (CDC): Advisory Committee on Immunization Practices (ACIP), 2015. MMWR 2015; 64(34): 948-9.
- Lee HJ, Choi JH. Tetanus-diphtheria-acellular pertussis vaccination for adults: an update. Clin Exp Vaccine Res. 2017 Jan; 6(1): 22-30. doi: 10.7774/cevr.2017.6.1.22. PMID: 28168170.
- Ansaldi F, Trucchi C, Alicino C, Paganino C, Orsi A, Icardi G. Real-world effectiveness and safety of a live-attenuated herpes zoster vaccine: a comprehensive review. Adv Ther. 2016 Jul; 33(7): 1094-104. doi: 10.1007/s12325-016-0355-0. PMID: 27262452.
- Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015 Oct; 28(5): 488-96. doi: 10.1097/QCO.0000000000000188. PMID: 26203853.
- Tajiri K, Shimizu Y. Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol. 2015 Jun 21; 21(23): 7074-83. doi: 10.3748/wjg.v21.i23.7074. PMID: 26109794.
- Falkenhorst G, Remschmidt C, Harder T, Hummers-Pradier E, Wichmann O, Bogdan C. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis.
- Centers for Disease Control and Prevention (CDC): Meningococcal vaccination - (https://www.cdc.gov/vaccines/vpd/mening/index.html)
- Centers for Disease Control and Prevention (CDC): Recommended immunization schedule for adults aged 19 years or older, by vaccine and age group, 2017 - (https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html)
- Malaria Vaccine Initiative (MVI): RTS,S - (http://www.malariavaccine.org/malaria-and-vaccines/first-generation-vaccine/rtss)
Editor: Suchitra Chari
Technically Checked by: Lingaraj
